伊布利特在持续性心房颤动射频消融术中转律的疗效特点

目的 评价伊布利特在持续性心房颤动(房颤)射频消融术中应用的有效性及影响因素.方法 入选接受射频消融手术的持续性房颤患者18例,男性16例,女性2例,平均年龄(56.3±14.0)岁,体质量(81.22±8.93) kg,合并原发性高血压3例、肥厚型心肌病2例.所有患者术中经环肺静脉电隔离、线性消融、碎裂电位消融后房颤未终止,或者转为心房扑动,给予伊布利特l mg、10min内静脉注射,观察开始给药后30 min内的转复率及4h内的不良反应.根据用药后是否成功转律分为转律组与非转律组.结果 (1)18例患者用药后30 min内成功转律11例,转复律为61.11％,平均转律时间为(13.80 +7.64) min,转复剂量为(0.94±0.13)mg.1例患者用药后15 min时出现窦性停搏16 s,后恢复稳定窦性心律,术后观察4h无不良反应,另1例患者用药后出现窦性心动过缓,持续约lh后恢复正常心率,期间无低血压等血流动力学改变.余16例患者术中及术后4h内无室性心动过速及低血压等不良反应.(2)使用伊布利特后30 min的AA间期(0.51±0.08)s,明显长于用药前的AA间期(0.39±0.21)s,P＜0.01;用药后30 min的QTc(0.51±0.08)s,明显长于用药前QTc(0.39±0.21)s,P＜0.01.(3)两组临床资料差异无统计学意义.转律组患者左房瘢痕区比例(5.12±3.83)％,明显小于非转律组左房瘢痕区比例(12.40±11.03)％,P＜0.01.(4)左心房内径＜40mm患者的转复率(75.00％)与内径≥40 mm患者的转复率(50.00％)差异无统计学意义(P＞0.05).结论 静脉注射伊布利特在持续性房颤射频消融术中应用疗效迅速,对消融后心房扑动转复率更高.转律的成功率与术中标测瘢痕区面积所占比例相关.

Efficacy of ibutilide for cardioversion of persistent atrial fibrillation during radiofrequency ablation

Objective The aim of this study was to investigate the efficiency and safety of ibutilide for cardioversion of persistent atrial fibrillation (AF) during radiofrequency ablation.Methods Eighteen patients (16 males) with persistent atrial fibrillation were enrolled in this study.All patients underwent circumferential pulmonary vein ablation guided by a Carto three-dimensional mapping systen.In addition,linear ablation at the top of the left atrium and the isthmus of mitral valves and complex fractionated atrial electrogram (CAFE) ablation were performed.All patients were still in either atrial fibrillation or atrial flutter after ablation,the patients were treated with l mg intravenous ibutilide injection within 10 minutes after unsuccessful ablation.Intravenous injection was stopped in case of sinus rhythm (SR) restoration or occurrence of severe adverse reactions such as ventricular tachycardia.Cardioversion rate within 30 min and adverse reactions within 4 h were observed.Patients were divided into either conversion group or nonconversion group according to whether AF was converted to sinus rhythm within 30 minutes after injection.Results Eleven patients (61.11％ ) converted to SR after ibutilide injection.There were no significant differences in gender,age,body mass index,left atrium and left ventricular function between conversion group and non-conversion groups.The average conversion time was ( 13.80 + 7.64 ) min,left atrium scar area ratio was significantly larger in non-conversion group ( 12.40 + 11.03 ) ％ than in conversion group (5.12 ±3.83)％,P ＜0.05.Ibutilide significantly prolonged the average wavelength of the AF wave ( 171.8 + 29.5 ) ms vs.(242.0 ± 40.0) ms at baseline,P ＜ 0.01.The QT interval at 30 min after ibutilide injection (0.39 ± 0.21 ) s was significantly longer than before injection (0.51 ± 0.08 ) s,P ＜ 0.05.There was no serious arrhythmias or other adverse reactions post ibutilide injection.Conclusions Ibutilide is highly effective and safe agent for cardioversion in patients underwent unsuccessful ablation.Left atrium scar area ratio is an important determinant for the conversion rate in this cohort.